Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Radiologie (Heidelb) ; 62(8): 692-700, 2022 Aug.
Article in German | MEDLINE | ID: mdl-35913573

ABSTRACT

The coronavirus pandemic has posed major challenges to clinical training. Innovative and interactive concepts are needed to maintain training for residents even in times of contact restrictions and distance rules. Training concepts for residents are underrepresented in the current literature. We present an innovative online-based training concept for radiology residents in our department, based on a tripartite design; independent case preparation where residents refer to existing knowledge is followed by a case discussion and specific questions and feedback from the participating senior physicians. A questionnaire-based evaluation of the training concept was carried out after 12 months. We found that participants rated the training concept positively when it came to difficulty, representativeness of clinical work and relevance for specialist training. The questionnaire responses also provided insights into the desired duration, the selection of imaging modalities, and frequency of the concept in the future. All respondents stated that they had benefited from the format. Online-based concepts can therefore be a relevant contribution to the clinical training of residents and represent an adequate alternative to or extension of analog concepts.


Subject(s)
COVID-19 , Internship and Residency , Physicians , Radiology , Humans , Pandemics , Radiology/education
2.
J Neurochem ; 138(6): 859-73, 2016 09.
Article in English | MEDLINE | ID: mdl-27167824

ABSTRACT

Argon has recently come into scientific focus as a neuroprotective agent. The underlying neuroprotective mechanism remains unknown although toll-like receptors were recently suggested to play an important role. We hypothesized that TLR-associated downstream transcription factors are responsible for argon's effects, leading to anti-apoptotic and anti-inflammatory properties. Apoptosis was induced in human neuroblastoma cells. Immediately afterwards, argon treatment (75 Vol% for 2 h) was initiated. Cells were analyzed, measuring mitochondrial membrane potential, reactive-oxygen-species, annexin-V/propidium iodide staining, transcription factor phosphorylation and binding activity as well as protein and mRNA expression of interleukins. Argon's in vivo effects were analyzed by quantification of retinal ganglion cell density, mRNA expression, serum cytokine analysis and immunohistochemistry after retinal ischemia reperfusion injury (IRI) in rats. Argon diminished rotenone-induced kappa-light-chain-enhancer' of activated B-cells (NF-κB) and signal transducer and activator of transcription 3 (STAT3) but not STAT5 or cAMP-response element-binding protein (CREB) phosphorylation and DNA-binding activity. Argon treatment attenuated apoptosis by preservation of mitochondrial membrane potential and decline in reactive oxygen species (ROS) generation. NF-κB and STAT3 inhibition, as well as TLR2 and TLR4 inhibition reversed argon's effects on IL-8 mRNA expression. Argon attenuated rotenone-induced IL-8 protein and mRNA expression in vitro. Inhibition of TLR2 and 4 attenuated argon's protective effect in vivo reducing IRI driven retinal IL-8 expression. IL-8 expression was found in the retina in co-localization with Müller cells and retinal ganglion cells. Argon mediates its neuroprotective effects by TLR-mediated regulation of transcription factors NF-κB and STAT3, thus decreasing interleukin-8 expression in vitro and in vivo. These findings may open up new opportunities to effectively treat cerebral ischemia and reperfusion injury through the inhalation of argon. Argon exerts its protective effects in vitro and in vivo via toll-like receptors TLR2 and TLR4 signaling, followed by alteration of downstream enzymes. In conclusion, argon mediates its beneficial effects by suppression of STAT3 and NF-κB phosphorylation and subsequent suppression of interleukin IL-8 protein expression. These novel findings may open up opportunities for argon as a therapeutic agent, particularly in the treatment of neuronal injury. Cover image for this issue: doi: 10.1111/jnc.13334.


Subject(s)
Apoptosis/drug effects , Argon/pharmacology , Interleukin-8/antagonists & inhibitors , Neuroblastoma/drug therapy , Neuroprotective Agents/pharmacology , Reperfusion Injury/prevention & control , Retinal Diseases/prevention & control , Signal Transduction/drug effects , Animals , Female , Humans , Male , Membrane Potential, Mitochondrial/drug effects , NF-kappa B/drug effects , NF-kappa B/metabolism , Neuroblastoma/pathology , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Reperfusion Injury/pathology , Retinal Diseases/pathology , STAT3 Transcription Factor/drug effects , STAT3 Transcription Factor/metabolism , Toll-Like Receptor 2/drug effects , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/drug effects , Toll-Like Receptor 4/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...